Delhi HC Dismisses Novo Nordisk’s Appeal To Block Dr Reddy’s Key Ozempic Ingredient Exports
The Delhi High Court on Monday backed Dr Reddy’s Laboratories Ltd. in its legal dispute with Novo Nordisk regarding the export and manufacture of semaglutide, a key ingredient for drugs such as Ozempic and Wegovy that are used in diabetes and chronic weight management respectively. […]
Top Story
